240 related articles for article (PubMed ID: 17334586)
21. Polymorphic CAG and GGC repeat lengths in the androgen receptor gene and prostate cancer risk: analysis of a Brazilian population.
Silva Neto B; Koff WJ; Biolchi V; Brenner C; Biolo KD; Spritzer PM; Brum IS
Cancer Invest; 2008 Feb; 26(1):74-80. PubMed ID: 18181049
[TBL] [Abstract][Full Text] [Related]
22. [Comparison of the number of CAG repeats in the gene for androgen receptors in a control Yugoslav population and in patients with schizophrenia].
Zamurović N; Culjković B; Stojković O; Zamurović B; Romac S
Srp Arh Celok Lek; 2000; 128(3-4):71-4. PubMed ID: 10932612
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the molecular consequences of different mutations at residue 754 and 690 of the androgen receptor (AR) and androgen insensitivity syndrome (AIS) phenotype.
Tadokoro R; Bunch T; Schwabe JW; Hughes IA; Murphy JC
Clin Endocrinol (Oxf); 2009 Aug; 71(2):253-60. PubMed ID: 19178528
[TBL] [Abstract][Full Text] [Related]
24. Increased risk of breast cancer in women bearing a combination of large CAG and GGN repeats in the exon 1 of the androgen receptor gene.
González A; Javier Dorta F; Rodriguez G; Brito B; Rodríguez MA; Cabrera A; Díaz-Chico JC; Reyes R; Aguirre-Jaime A; Nicolás Díaz-Chico B
Eur J Cancer; 2007 Nov; 43(16):2373-80. PubMed ID: 17728127
[TBL] [Abstract][Full Text] [Related]
25. The role of sex hormone-binding globulin and androgen receptor gene variants in the development of polycystic ovary syndrome.
Xita N; Georgiou I; Lazaros L; Psofaki V; Kolios G; Tsatsoulis A
Hum Reprod; 2008 Mar; 23(3):693-8. PubMed ID: 18192296
[TBL] [Abstract][Full Text] [Related]
26. Somatic mosaicism of androgen receptor CAG repeats in colorectal carcinoma epithelial cells from men.
Di Fabio F; Alvarado C; Gologan A; Youssef E; Voda L; Mitmaker E; Beitel LK; Gordon PH; Trifiro M
J Surg Res; 2009 Jun; 154(1):38-44. PubMed ID: 19062046
[TBL] [Abstract][Full Text] [Related]
27. Study of androgen receptor functions by genetic models.
Matsumoto T; Takeyama K; Sato T; Kato S
J Biochem; 2005 Aug; 138(2):105-10. PubMed ID: 16091584
[TBL] [Abstract][Full Text] [Related]
28. Molecular genetics of androgen insensitivity syndromes.
Lobaccaro JM; Lumbroso S; Poujol N; Belon C; Sultan C
Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):301-8. PubMed ID: 7920176
[TBL] [Abstract][Full Text] [Related]
29. Somatic mosaicism and cancer: a micro-genetic examination into the role of the androgen receptor gene in prostate cancer.
Alvarado C; Beitel LK; Sircar K; Aprikian A; Trifiro M; Gottlieb B
Cancer Res; 2005 Sep; 65(18):8514-8. PubMed ID: 16166332
[TBL] [Abstract][Full Text] [Related]
30. CAG repeat polymorphism in the androgen receptor (AR) gene of SBMA patients and a control group.
Sułek A; Hoffman-Zacharska D; Krysa W; Szirkowiec W; Fidziańska E; Zaremba J
J Appl Genet; 2005; 46(2):237-9. PubMed ID: 15876692
[TBL] [Abstract][Full Text] [Related]
31. Androgen receptor gene haplotype is associated with male infertility.
Saare M; Belousova A; Punab M; Peters M; Haller K; Ausmees K; Poolamets O; Karro H; Metspalu A; Salumets A
Int J Androl; 2008 Aug; 31(4):395-402. PubMed ID: 17651405
[TBL] [Abstract][Full Text] [Related]
32. Structural dynamics of the human androgen receptor: implications for prostate cancer and neurodegenerative disease.
Duff J; Davies P; Watt K; McEwan IJ
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1098-102. PubMed ID: 17073759
[TBL] [Abstract][Full Text] [Related]
33. Androgen receptor gene CAG repeats, estrogen exposure status, and breast cancer susceptibility.
Wu MH; Chou YC; Yu CP; Yang T; You SL; Chen CJ; Sun CA
Eur J Cancer Prev; 2008 Aug; 17(4):317-22. PubMed ID: 18562955
[TBL] [Abstract][Full Text] [Related]
34. Shorter CAG repeats in the androgen receptor gene may enhance hyperandrogenicity in polycystic ovary syndrome.
Van Nieuwerburgh F; Stoop D; Cabri P; Dhont M; Deforce D; De Sutter P
Gynecol Endocrinol; 2008 Dec; 24(12):669-73. PubMed ID: 19172534
[TBL] [Abstract][Full Text] [Related]
35. Androgen receptor gene polymorphism may affect the risk of urothelial carcinoma.
Liu CH; Huang JD; Huang SW; Hour TC; Huang YK; Hsueh YM; Chiou HY; Lee TC; Jan KY; Chen CJ; Pu YS
J Biomed Sci; 2008 Mar; 15(2):261-9. PubMed ID: 17922225
[TBL] [Abstract][Full Text] [Related]
36. Complete androgen insensitivity without Wolffian duct development: the AR-A form of the androgen receptor is not sufficient for male genital development.
Barbaro M; Oscarson M; Almskog I; Hamberg H; Wedell A
Clin Endocrinol (Oxf); 2007 Jun; 66(6):822-6. PubMed ID: 17408421
[TBL] [Abstract][Full Text] [Related]
37. Correlation between genotype, phenotype and sex of rearing in 111 patients with partial androgen insensitivity syndrome.
Deeb A; Mason C; Lee YS; Hughes IA
Clin Endocrinol (Oxf); 2005 Jul; 63(1):56-62. PubMed ID: 15963062
[TBL] [Abstract][Full Text] [Related]
38. CAG repeat polymorphism in the androgen receptor: a study on the effect of different numbers of repeats using Gene Ontology technique.
Wiwanitkit V
Fertil Steril; 2009 Jan; 91(1):e5-6. PubMed ID: 18222439
[TBL] [Abstract][Full Text] [Related]
39. Long-term followup and comparison between genotype and phenotype in 29 cases of complete androgen insensitivity syndrome.
Cheikhelard A; Morel Y; Thibaud E; Lortat-Jacob S; Jaubert F; Polak M; Nihoul-Fekete C
J Urol; 2008 Oct; 180(4):1496-501. PubMed ID: 18710728
[TBL] [Abstract][Full Text] [Related]
40. Identification of a critical novel mutation in the exon 1 of androgen receptor gene in 2 brothers with complete androgen insensitivity syndrome.
Radpour R; Falah M; Aslani A; Zhong XY; Saleki A
J Androl; 2009; 30(3):230-2. PubMed ID: 19023143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
